Re-irradiation for salvage of prostate cancer failures after primary radiotherapy

World Journal of Urology

Volumn 31, Issue 6, 2013, Pages 1339-1345

  Ramey, Stephen J ^a   Marshall, David T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Brachytherapy; Local failure; Prostate cancer; Re irradiation; Salvage radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BLOOD; BRACHYTHERAPY; HUMAN; MALE; METHODOLOGY; MORTALITY; PROSTATE TUMOR; RADIOTHERAPY; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR RECURRENCE;

BRACHYTHERAPY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84888305856     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-012-0953-7     Document Type: Article

References (35)

1. American Cancer Society (2012) Cancer Facts & Figures 2012. http://www. cancer. org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941. pdf. Accessed 6/24/12.
2. Alicikus ZA, Yamada Y, Zhang Z, Pei X, Hunt M, Kollmeier M, Cox B, Zelefsky MJ (2011) Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer 117(7): 1429-1437. doi: 10. 1002/cncr. 25467.
3. Sylvester JE, Grimm PD, Wong J, Galbreath RW, Merrick G, Blasko JC (2011) Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience. Int J Radiat Oncol Biol Phys 81(2): 376-381. doi: 10. 1016/j. ijrobp. 2010. 05. 042.
4. Kuban DA, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL (2003) Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 57(4): 915-928.
5. Crook J, Borg J, Evans A, Toi A, Saibishkumar EP, Fung S, Ma C (2011) 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1, 100 patients. Int J Radiat Oncol Biol Phys 80(5): 1323-1329. doi: 10. 1016/j. ijrobp. 2010. 04. 038.
6. Sylvester J, Grimm P, Blasko J, Meier R, Heaney C, Cavanaugh WA (2001) Transperineal permanent brachytherapy for local recurrence following external beam radiation for early-stage prostate cancer. J Brachytherapy Int 17: 181-188.
7. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW (2007) Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality. J Clin Oncol Off J Am Soc Clin Oncol 25(13): 1765-1771. doi: 10. 1200/jco. 2006. 08. 0572.
8. Leibovici D, Spiess PE, Heller L, Rodriguez-Bigas M, Chang G, Pisters LL (2008) Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Urol Oncol 26(1): 9-16. doi: 10. 1016/j. urolonc. 2006. 12. 016.
9. Clarke HS Jr, Eskridge MR, El-Zawahry AM, Keane TE (2007) Salvage cryosurgical ablation of the prostate for local recurrence after radiation therapy: improved outcomes utilizing a capromab pendetide scan and biopsy algorithm. Can J Urol 14(Suppl 1): 24-27.
10. Finley DS, Belldegrun AS (2011) Salvage cryotherapy for radiation-recurrent prostate cancer: outcomes and complications. Curr Urol Reports 12(3): 209-215. doi: 10. 1007/s11934-011-0182-4.
11. Lukka H, Waldron T, Chin J, Mayhew L, Warde P, Winquist E, Rodrigues G, Shayegan B (2011) High-intensity focused ultrasound for prostate cancer: a systematic review. Clin Oncol (Royal College of Radiologists (Great Britain)) 23 (2): 117-127 doi: 10. 1016/j. clon. 2010. 09. 002.
12. Beyer DC (2003) Brachytherapy for recurrent prostate cancer after radiation therapy. Sem Rad Oncol 13(2): 158-165. doi: 10. 1053/srao. 2003. 50015.
13. Nguyen PL, D'Amico AV, Lee AK, Suh WW (2007) Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer 110(7): 1417-1428. doi: 10. 1002/cncr. 22941.
14. Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, van der Kwast T, Wiegel T, Zattoni F, Heidenreich A (2011) EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59(4): 572-583. doi: 10. 1016/j. eururo. 2011. 01. 025.
15. Abouassaly R, Paciorek A, Ryan CJ, Carroll PR, Klein EA (2009) Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE. Cancer 115(19): 4470-4476. doi: 10. 1002/cncr. 24526.
16. Crook JM, Choan E, Perry GA, Robertson S, Esche BA (1998) Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure. Urology 51(4): 566-572.
17. Aaronson DS, Yamasaki I, Gottschalk A, Speight J, Hsu IC, Pickett B, Roach M 3rd, Shinohara K (2009) Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. BJU Int 104(5): 600-604. doi: 10. 1111/j. 1464-410X. 2009. 08445. x.
18. Allen GW, Howard AR, Jarrard DF, Ritter MA (2007) Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option. Cancer 110(7): 1405-1416. doi: 10. 1002/cncr. 22940.
19. Beyer DC (1999) Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 54(5): 880-883.
20. Burri RJ, Stone NN, Unger P, Stock RG (2010) Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 77(5): 1338-1344. doi: 10. 1016/j. ijrobp. 2009. 06. 061.
21. Cumes DM, Goffinet DR, Martinez A, Stamey TA (1981) Complication of 125 iodine implantation and pelvic lymphadenectomy for prostatic cancer with special reference to patients who had failed external beam therapy as their initial mode of therapy. J Urol 126(5): 620-622.
22. Dattoli M, Cash J, Ross R, Geohagen B, Palm J, Koval J, Sorace R (1997) Neoadjuvant hormone therapy and palladium-103 brachytherapy as salvage for locally recurrent prostate cancer. Proc Am Soc Clin Oncol 16: 1118. (Abstract).
23. Grado GL, Collins JM, Kriegshauser JS, Balch CS, Grado MM, Swanson GP, Larson TR, Wilkes MM, Navickis RJ (1999) Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53(1): 2-10.
24. Jo Y, Fujii T, Hara R, Yokoyama T, Miyaji Y, Yoden E, Hiratsuka J, Nagai A (2012) Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy: preliminary results. BJU Int 109(6): 835-839. doi: 10. 1111/j. 1464-410X. 2011. 10519. x.
25. Koutrouvelis P, Hendricks F, Lailas N, Gil-Montero G, Sehn J, Khawand N, Bondy H, Katz S (2003) Salvage reimplantation in patient with local recurrent prostate carcinoma after brachytherapy with three dimensional computed tomography-guided permanent pararectal implant. Technol Cancer Res Treat 2(4): 339-344.
26. Lee B, Shinohara K, Weinberg V, Gottschalk AR, Pouliot J, Roach M 3rd, Hsu IC (2007) Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 67(4): 1106-1112. doi: 10. 1016/j. ijrobp. 2006. 10. 012.
27. Lee HK, Adams MT, Motta J (2008) Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy. Brachytherapy 7(1): 17-21. doi: 10. 1016/j. brachy. 2007. 11. 002.
28. Loening SA, Turner JW (1993) Use of percutaneous transperineal 198Au seeds to treat recurrent prostate adenocarcinoma after failure of definitive radiotherapy. Prostate 23(4): 283-290.
29. Moman MR, van der Poel HG, Battermann JJ, Moerland MA, van Vulpen M (2010) Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy. Brachytherapy 9(2): 119-125. doi: 10. 1016/j. brachy. 2009. 06. 007.
30. Nguyen PL, Chen MH, D'Amico AV, Tempany CM, Steele GS, Albert M, Cormack RA, Carr-Locke DL, Bleday R, Suh WW (2007) Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer 110(7): 1485-1492. doi: 10. 1002/cncr. 22934.
31. Teh BS, Berner BM, Carpenter LS, Chiu JK, Dennis WS, Lu HH, Woo SY, Butler EB (1998) Permanent Gold-198 Implant for locally recurrent adenocarcinoma of the prostate after failing initial radiotherapy. J Brachytherapy Int 14: 233-240.
32. Tharp M, Hardacre M, Bennett R, Jones WT, Stuhldreher D, Vaught J (2008) Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer. Brachytherapy 7(3): 231-236. doi: 10. 1016/j. brachy. 2008. 03. 003.
33. Wallner KE, Nori D, Morse MJ, Sogani PC, Whitmore WF, Fuks Z (1990) 125iodine reimplantation for locally progressive prostatic carcinoma. J Urol 144(3): 704-706.
34. Wong WW, Buskirk SJ, Schild SE, Prussak KA, Davis BJ (2006) Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol 176(5): 2020-2024. doi: 10. 1016/j. juro. 2006. 07. 008.
35. Butler EB, Scardino PT, Teh BS, Uhl BM, Guerriero WG, Carlton CE, Berner BM, Dennis WS, Carpenter LS, Lu HH, Chiu JK, Kent TS, Woo SY (1997) The Baylor College of Medicine experience with gold seed implantation. Semin Surg Oncol 13(6): 406-418.